SCHEMBL7652942

SCHEMBL7652942

C=C(C)C1c2cc(NC(=O)c3ccc(OC)c(C(F)(F)F)c3)ccc2CCN1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
TP53 P04637 1/20 0.47
THRB P10828 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BRAF P15056 10/20 0.46
RAF1 P04049 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42
ROCK2 O75116 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7660377 0.87 MAPT (0.52) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7661476 0.85 MAPT (0.48) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7658503 0.84 MAPT (0.47) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7657978 0.83 MAPT (0.45) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7653743 0.82 MAPT (0.47) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7655655 0.81 ROCK2 (0.47) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7012602 0.80 MAPT (0.49) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL6293655 0.80 ROCK2 (0.61) MAPTTP53THRBSMN1; SMN2BRAF
Hydrochloric Acid SCHEMBL7014137 0.80 MAPT (0.49) MAPTTP53THRBSMN1; SMN2BRAF
SCHEMBL7661456 0.79 RORC (0.47) MAPTTP53SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492378-B1 Substituted isoquinoline derivatives and their use as anticonvulsivants SMITHKLINE BEECHAM P.L.C. (GB) 2002-12-10 US disclosed